Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karin Mayer

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
World Journal of Pediatrics : WJP|April 10, 2016
Rare co-occurrence of osteogenesis imperfecta type I and autosomal dominant polycystic kidney diseaseJulia Hoefele, Karin Mayer, Christoph Marschall, et al.
International Urology and Nephrology|October 12, 2012
Nephron-sparing resection of angiomyolipoma after sirolimus pretreatment in patients with tuberous sclerosisMichael Staehler, Matthias Sauter, Andreas Helck, et al.
Journal of Pharmacological and Toxicological Methods|April 25, 2008
Evaluation of cardiovascular and ECG parameters in the normal, freely moving Göttingen MinipigMiriam Stubhan, Michael Markert, Karin Mayer, et al.
Frontiers in Oncology|September 18, 2025
Chronification of metastatic leiomyosarcoma in 9 lines of therapy by precision oncology: a case report and review of the literatureChristian R Klein, Sebastian Koob, Verena Tischler, et al.
Archives of Gynecology and Obstetrics|November 8, 2017
Successful treatment of acute promyelocytic leukemia in pregnancy with single-agent all-trans retinoic acidCordula M Nellessen, Viktor Janzen, Karin Mayer, et al.
American Journal of Medical Genetics. Part A|July 26, 2017
Biallelic COL3A1 mutations result in a clinical spectrum of specific structural brain anomalies and connective tissue abnormalitiesDenise Horn, Eberhard Siebert, Ulrich Seidel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 2, 2017
Safety of multiple repeated cycles of <sup>177</sup>Lu-octreotate in patients with recurrent neuroendocrine tumourAnna Yordanova, Karin Mayer, Peter Brossart, et al.
Journal of Pharmacological and Toxicological Methods|May 12, 2009
Validation of the normal, freely moving Göttingen minipig for pharmacological safety testingMichael Markert, Miriam Stubhan, Karin Mayer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 27, 2015
Specific efficacy of peptide receptor radionuclide therapy with (177)Lu-octreotate in advanced neuroendocrine tumours of the small intestineAmir Sabet, Kristina Dautzenberg, Torjan Haslerud, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 7, 2013
Long-term hematotoxicity after peptide receptor radionuclide therapy with 177Lu-octreotateAmir Sabet, Khaled Ezziddin, Ulrich-Frank Pape, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
World Journal of Pediatrics : WJP|April 10, 2016
Rare co-occurrence of osteogenesis imperfecta type I and autosomal dominant polycystic kidney diseaseJulia Hoefele, Karin Mayer, Christoph Marschall, et al.
International Urology and Nephrology|October 12, 2012
Nephron-sparing resection of angiomyolipoma after sirolimus pretreatment in patients with tuberous sclerosisMichael Staehler, Matthias Sauter, Andreas Helck, et al.
Journal of Pharmacological and Toxicological Methods|April 25, 2008
Evaluation of cardiovascular and ECG parameters in the normal, freely moving Göttingen MinipigMiriam Stubhan, Michael Markert, Karin Mayer, et al.
Frontiers in Oncology|September 18, 2025
Chronification of metastatic leiomyosarcoma in 9 lines of therapy by precision oncology: a case report and review of the literatureChristian R Klein, Sebastian Koob, Verena Tischler, et al.
Archives of Gynecology and Obstetrics|November 8, 2017
Successful treatment of acute promyelocytic leukemia in pregnancy with single-agent all-trans retinoic acidCordula M Nellessen, Viktor Janzen, Karin Mayer, et al.
American Journal of Medical Genetics. Part A|July 26, 2017
Biallelic COL3A1 mutations result in a clinical spectrum of specific structural brain anomalies and connective tissue abnormalitiesDenise Horn, Eberhard Siebert, Ulrich Seidel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 2, 2017
Safety of multiple repeated cycles of <sup>177</sup>Lu-octreotate in patients with recurrent neuroendocrine tumourAnna Yordanova, Karin Mayer, Peter Brossart, et al.
Journal of Pharmacological and Toxicological Methods|May 12, 2009
Validation of the normal, freely moving Göttingen minipig for pharmacological safety testingMichael Markert, Miriam Stubhan, Karin Mayer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 27, 2015
Specific efficacy of peptide receptor radionuclide therapy with (177)Lu-octreotate in advanced neuroendocrine tumours of the small intestineAmir Sabet, Kristina Dautzenberg, Torjan Haslerud, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 7, 2013
Long-term hematotoxicity after peptide receptor radionuclide therapy with 177Lu-octreotateAmir Sabet, Khaled Ezziddin, Ulrich-Frank Pape, et al.
Pageof 6